A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV1) than those patients who have stopped smoking.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2007-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2007/192961 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546999879073792 |
|---|---|
| author | Charles KN Chan François Maltais Chris Sigouin Jennifer M Haddon Gordon T Ford on behalf of the SAFE Study Group |
| author_facet | Charles KN Chan François Maltais Chris Sigouin Jennifer M Haddon Gordon T Ford on behalf of the SAFE Study Group |
| author_sort | Charles KN Chan |
| collection | DOAJ |
| description | BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV1) than those patients who have stopped smoking. |
| format | Article |
| id | doaj-art-32bd8013b4db4094a504b89d167c76ae |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2007-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-32bd8013b4db4094a504b89d167c76ae2025-02-03T06:46:20ZengWileyCanadian Respiratory Journal1198-22412007-01-0114846547210.1155/2007/192961A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary DiseaseCharles KN Chan0François Maltais1Chris Sigouin2Jennifer M Haddon3Gordon T Ford4on behalf of the SAFE Study GroupUniversity Health Network – Toronto General Hospital, Toronto, Ontario, CanadaCentre de recherche de l’Hôpital Laval, Institut universitaire de cardiologie et de pneumologie de l’Université Laval, Laval, Québec, CanadaUniversity of Toronto, Department of Health Policy, Management and Evaluation, Toronto, CanadaBoehringer Ingelheim Canada Limited, Burlington, Ontario, CanadaRespiratory Division, University of Calgary, Calgary, Alberta, CanadaBACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV1) than those patients who have stopped smoking.http://dx.doi.org/10.1155/2007/192961 |
| spellingShingle | Charles KN Chan François Maltais Chris Sigouin Jennifer M Haddon Gordon T Ford on behalf of the SAFE Study Group A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease Canadian Respiratory Journal |
| title | A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease |
| title_full | A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease |
| title_fullStr | A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease |
| title_full_unstemmed | A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease |
| title_short | A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease |
| title_sort | randomized controlled trial to assess the efficacy of tiotropium in canadian patients with chronic obstructive pulmonary disease |
| url | http://dx.doi.org/10.1155/2007/192961 |
| work_keys_str_mv | AT charlesknchan arandomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT francoismaltais arandomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT chrissigouin arandomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT jennifermhaddon arandomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT gordontford arandomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT onbehalfofthesafestudygroup arandomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT charlesknchan randomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT francoismaltais randomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT chrissigouin randomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT jennifermhaddon randomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT gordontford randomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease AT onbehalfofthesafestudygroup randomizedcontrolledtrialtoassesstheefficacyoftiotropiumincanadianpatientswithchronicobstructivepulmonarydisease |